Technology commercialization risk - unproven ability to scale pilot processes to commercial production with competitive economics versus incumbent chemical manufacturers
Regulatory and policy risk - dependence on clean energy subsidies, carbon pricing mechanisms, or environmental regulations that could change with political shifts
Capital intensity - requirement for substantial additional funding to reach commercial scale, with dilution risk to existing shareholders
Competition from established chemical companies (BASF, Dow, LyondellBasell) investing in their own clean technology initiatives with deeper resources
Alternative clean chemical technologies or production methods that could render FMST's approach obsolete
Low-cost incumbent producers with existing infrastructure and customer relationships creating high barriers to market entry
Negative operating cash flow of approximately $13.1M (implied by FCF yield) creates ongoing funding requirements and potential dilution
Pre-revenue status means no organic cash generation to fund operations, requiring continued access to capital markets
ROE of -12.3% and ROA of -9.8% reflect ongoing losses during development phase, with uncertainty around path to profitability
StructuralCompetitiveBalance Sheet